mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
0.072 |
0.7 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |